A Scientific Advisory Board of external scientists serves as an external consultant to the department, assisting the governance bodies by providing advice and perspective. Members of the Advisory Board are appointed by the Chairman after discussion with the Scientific Council. Ad hoc meetings with the Advisory Board are organized in case of need; for instance, it is valuable the role played by the Advisory Board in the tenure track evaluation.
The DEO Advisory Board is composed of renowned scientists, such as Dr. Genevieve Almouzni, Honorary Director of the Research Centre at the Institut Curie and Director of Research Exceptional Class at the CNRS (Paris); Prof. Ido Amit, Head the Laboratory of Immuno-Genomics of the Weizmann Institute of Science; Dr. Jo Bury, managing director of the Flanders Institute for Biotechnology (VIB); Prof. Riccardo Dalla Favera, Director of the Cancer Genetics Institute of Columbia University (New York); Prof. Kristian Helin, CEO and President of The Institute of Cancer Research (ICR) and Prof. Dr. Ana Martin-Villalba, Head, Division of Molecular Neurobiology, Chair of the Scientific Council of the German Cancer Research Center (DKFZ).